Apr 20, 2017· Comment from American Pharmacists Association (APhA)· FDA-2016-D-1307-0024
Please see attached for comments from the American Pharmacists Association.
FDANonrulemakingFDA-2016-D-1307
Questions and Answers Regarding Drug and Device Manufacturer Communications with Payors; Draft Guidance for Industry; Availability
RIN
—
Last modified
Jun 11, 2026
Comment window
closes in 6d
American Pharmacists Association (APhA) filings
1
Activity
American Pharmacists Association (APhA) filed 1 comment on this docket between Apr 20, 2017 and Apr 20, 2017. 9 other organizations filed here. The comment window closes in 6d.
What American Pharmacists Association (APhA) filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (9)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG1 filing · confidence 97%
- National Pharmaceutical Counciltrade assoc.2 filings · confidence 85%
- Advanced Medical Technology Associationtrade assoc.1 filing · confidence 97%
- American Association of Nurse Practitionerstrade assoc.1 filing · confidence 85%
- Anthem and Eli Lilly and Companyunverified attribution1 filing · confidence 70%
- Blue Cross Blue Shield Associationtrade assoc.1 filing · confidence 85%
- Medical Device Manufacturers Associationtrade assoc.1 filing · confidence 85%
- Pharmaceutical Care Management Associationtrade assoc.1 filing · confidence 85%
- Sunovion Pharmaceuticals Inc.unverified attribution1 filing · confidence 70%
- Washington Legal Foundationtrade assoc.1 filing · confidence 85%